BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24800484)

  • 1. [Treatment of arteril hypertension in patients with chronic kidney disease: a fixed combination of lercanidipine and enalapril].
    Minushkina LO
    Kardiologiia; 2013; 53(12):64-9. PubMed ID: 24800484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril.
    Borghi C; Cicero AF
    Clin Drug Investig; 2010; 30(12):843-54. PubMed ID: 20923243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension.
    Rump LC
    Arzneimittelforschung; 2010; 60(3):124-30. PubMed ID: 20422943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the fixed-dose combination lercanidipine-enalapril in renal protection.
    Egan CG; Pontremoli R
    J Nephrol; 2011; 24(4):428-37. PubMed ID: 21279953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril.
    Chatzikyrkou C; Haller H; Menne J
    Expert Opin Pharmacother; 2009 Aug; 10(11):1833-40. PubMed ID: 19527194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Fixed Lercanidipine/Enalapril Combination on 24-Hour Blood Pressure Proffie in Elderly Patients With Arterial Hypertension].
    Gosteva EV; Vasil'eva LV
    Kardiologiia; 2015; 55(2):32-6. PubMed ID: 26164986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lercanidipine valuable effect on urine protein losses: the RED LEVEL study.
    Robles NR; Calvo C; Sobrino J; Espinel E; Esteban R; Mateos L; Macias JF
    Curr Med Res Opin; 2016 Oct; 32(sup2):29-34. PubMed ID: 27779460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension.
    De Ciuceis C; Salvetti M; Rossini C; Muiesan ML; Paini A; Duse S; La Boria E; Semeraro F; Cancarini A; Rosei CA; Sarkar A; Ruggeri G; Caimi L; Ricotta D; Rizzoni D; Rosei EA
    J Hypertens; 2014 Mar; 32(3):565-74. PubMed ID: 24378999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on target organ damage and sympathetic activation in non-obese essential hypertensive subjects.
    Tsioufis K; Tsioufis C; Dimitriadis K; Mantzouranis E; Mani I; Tousoulis D
    Curr Med Res Opin; 2016 Oct; 32(sup2):35-41. PubMed ID: 27779461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C; Stabouli S; Kotsis V
    Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of a lercanidipine/enalapril fixed-dose combination in hypertensive patients in Portugal.
    Maldonado J; Pereira T; Tavares A
    Drugs R D; 2014 Jun; 14(2):147-54. PubMed ID: 24831818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed-dose lercanidipine and enalapril in field practice: a meta-analysis.
    Rizzoni D
    Curr Med Res Opin; 2016 Oct; 32(sup2):13-15. PubMed ID: 27779457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressure.
    Scholze J; Bramlage P; Trenkwalder P; Kreutz R
    Expert Opin Pharmacother; 2011 Dec; 12(18):2771-9. PubMed ID: 21999703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril.
    Barrios V; Escobar C; Echarri R
    Vasc Health Risk Manag; 2008; 4(4):847-53. PubMed ID: 19066001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed-dose combination lercanidipine/enalapril.
    Hair PI; Scott LJ; Perry CM
    Drugs; 2007; 67(1):95-106; discussion 107-8. PubMed ID: 17209666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response effect of the lercanidipine/enalapril combination: a pooled analysis.
    Rizzoni D
    Curr Med Res Opin; 2016 Oct; 32(sup2):17-23. PubMed ID: 27779458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed-dose lercanidipine/enalapril for hypertension.
    Menne J; Haller H
    Drugs Today (Barc); 2008 Apr; 44(4):261-70. PubMed ID: 18536784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients.
    Derosa G; Bonaventura A; Romano D; Bianchi L; Fogari E; D'Angelo A; Maffioli P
    J Clin Pharm Ther; 2014 Jun; 39(3):277-85. PubMed ID: 24635387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.